Product information

Current status:

Cancelled Post Market

Current status date:

2003-12-03

Original market date: ^{See footnote 1}

1996-12-31

Product name:

VIVELLE 37.5MCG

DIN:

02204401 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Patch

Route(s) of administration:

Transdermal

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

68:16.04 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

G03CA03 ESTRADIOL

Active ingredient group (AIG) number:^{See footnote5}

0106457008